SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001636050-17-000056
Filing Date
2017-11-02
Accepted
2017-11-02 16:37:33
Documents
3
Period of Report
2017-11-02
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a093020178-k.htm 8-K 27820
2 EXHIBIT 99.1 a093017ex991.htm EX-99.1 109264
3 axovantlogooctober2017.jpg GRAPHIC 12484
  Complete submission text file 0001636050-17-000056.txt   150296
Mailing Address 20-22 BEDFORD ROW LONDON X0 WC1R 4JS
Business Address 20-22 BEDFORD ROW LONDON X0 WC1R 4JS 441-295-5950
Axovant Sciences Ltd. (Filer) CIK: 0001636050 (see all company filings)

IRS No.: 000000000 | State of Incorp.: D0 | Fiscal Year End: 0331
Type: 8-K | Act: 34 | File No.: 001-37418 | Film No.: 171172986
SIC: 2834 Pharmaceutical Preparations